Adolescent tuberculosis
Snow KJ, Cruz AT, Seddon JA, Ferrand RA, Chiang SS, Hughes JA, Kampmann B, Graham SM, et al. (13 authors)
The Lancet. Child & adolescent health · 2019-11
Abstract
Adolescence is characterised by a substantial increase in the incidence of tuberculosis, a known fact since the early 20th century. Most of the world's adolescents live in low-income and middle-income countries where tuberculosis remains common, and where they comprise a quarter of the population. Despite this, adolescents have not yet been addressed as a distinct population in tuberculosis policy or within tuberculosis treatment services, and emerging evidence suggests that current models of care do not meet their needs. This Review discusses up-to-date information about tuberculosis in adolescence, with a focus on the management of infection and disease, including HIV co-infection and rifampicin-resistant tuberculosis. We outline the progress in vaccine development and highlight important directions for future research.
MeSH terms
- Humans
- Tuberculosis
- Tuberculosis, Multidrug-Resistant
- HIV Infections
- Tuberculosis Vaccines
- Antitubercular Agents
- Incidence
- Developing Countries
- Adolescent
- Child
- Young Adult
- Coinfection